Celldex Therapeutics (CLDX) Interest Coverage Ratio Growth (3y) (2013 - 2026)
Celldex Therapeutics (CLDX) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -11.54% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 82.53% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 43.08% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 28.57% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -26.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -24.77% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 33.30% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 81.16% |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 2.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.56% |
| Mar 31, 2026 | -56.06% |
| Dec 31, 2025 | -6,152.09% |
| Sep 30, 2025 | -1,238.74% |
| Jun 30, 2025 | -255.16% |
| Mar 31, 2025 | -243.87% |
| Dec 31, 2024 | -37.62% |
| Sep 30, 2024 | -150.77% |
| Dec 31, 2023 | -17.25% |
| Dec 31, 2022 | -26.31% |
| Sep 30, 2022 | 23.13% |
| Jun 30, 2022 | 32.58% |
| Mar 31, 2022 | 45.47% |
| Dec 31, 2021 | -17.61% |
| Dec 31, 2020 | 4.12% |
| Dec 31, 2018 | 30.28% |
| Dec 31, 2017 | 13.21% |
| Dec 31, 2015 | -26.15% |
| Dec 31, 2014 | 82.65% |
| Dec 31, 2013 | -43.52% |